Measles Epidemiology in Ethiopia from 2006 - 2016: Predictors of High Measles Incidence from Surveillance Data Analysis

Desta, Teklay; Lemango, Ephrem Tekle; Wayess, Jimma D; Maternal, Balcha G Masresha; Ethiopia, Fmoh; Box, PO; Ababa, Addis; Box, Fmoh. P.O.; Africa, Regional Office for; Brazzaville,; Congo,

doi:10.29245/2578-3009/2018/si.1118

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Somali for instance, Penta3 coverage ranged from less than 5% to around 85% across woredas; even in urban areas where relatively disparities are lower, like Addis Ababa, the smallest MCV1 coverage (83%) was far lower than the 100% coverage estimates for several other sub-city woredas. Overall, we found that MCV1 coverage in many woredas was far lower than 95%, the threshold indicated for measles elimination goals [ 32 ]: 87% of woredas presented MCV1 coverage below 95%, 54% of them being in Oromia. Active measles outbreaks have been ongoing in the country since January 2022 and as of August 2022 around 4,000 confirmed cases had been reported [ 33 , 34 ].…”

Section: Discussionmentioning

confidence: 99%

Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia

Tesfaye,

Forzy,

Getnet

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

Ethiopia has made significant progress in the last two decades in improving the availability and coverage of essential maternal and child health services including childhood immunizations. As Ethiopia keeps momentum towards achieving national immunization goals, methods must be developed to analyze routinely collected health facility data and generate localized coverage estimates. This study leverages the District Health Information Software (DHIS2) platform to estimate immunization coverage for the first dose of measles vaccine (MCV1) and the third dose of diphtheria-pertussis-tetanus-Hib-HepB vaccine (Penta3) across Ethiopian districts (“woredas”). Monthly reported numbers of administered MCV1 and Penta3 immunizations were extracted from public facilities from DHIS2 for 2017/2018-2021/2022 and corrected for quality based on completeness and consistency across time and districts. We then utilized three sources for the target population (infants) to compute administrative coverage estimates: Central Statistical Agency, DHIS2, and WorldPop. The Ethiopian Demographic and Health Surveys were used as benchmarks to which administrative estimates were adjusted at the regional level. Administrative vaccine coverage was estimated for all woredas, and, after adjustments, was bounded within 0–100%. In regions with the highest immunization coverage, MCV1 coverage would range from 83 to 100% and Penta3 coverage from 88 to 100% (Addis Ababa, 2021/2022); MCV1 from 8 to 100% and Penta3 from 4 to 100% (Tigray, 2019/2020). Nationally, the Gini index for MCV1 was 0.37, from 0.13 (Harari) to 0.37 (Somali); for Penta3, it was 0.36, from 0.16 (Harari) to 0.36 (Somali). The use of routine health information systems, such as DHIS2, combined with household surveys permits the generation of local health services coverage estimates. This enables the design of tailored health policies with the capacity to measure progress towards achieving national targets, especially in terms of inequality reductions.

show abstract

Section: Discussionmentioning

confidence: 99%

Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia

Tesfaye,

Forzy,

Getnet

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

show abstract

“…Measles is considered the most contagious viral disease known, and its incidence in Ethiopia is high, with 49 cases per million population in 2016. 13 The incubation period ranges from 7 to 21 days from exposure to onset of fever. A clinical diagnosis of measles can be made from the clinical features of generalized maculopapular rash lasting for 3 or more days, temperature of 38.3°C (100.9°F) or higher, and cough, coryza, and conjunctivitis.…”

Section: Measlesmentioning

confidence: 99%

Fever in a traveler returning from Ethiopia

Wong

2020

CCJM

View full text Add to dashboard Cite

Measles Epidemiology in Ethiopia from 2006 - 2016: Predictors of High Measles Incidence from Surveillance Data Analysis

Cited by 2 publications

References 5 publications

Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia

Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia

Fever in a traveler returning from Ethiopia

Contact Info

Product

Resources

About